These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27393712)

  • 1. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
    Aribas A; Kayrak M; Tekinalp M; Akilli H; Alibasic H; Yildirim S; Gunduz M; Taner A; Unlu A
    Korean J Intern Med; 2015 May; 30(3):316-24. PubMed ID: 25995662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction.
    Lehmann HI; Goette A; Martens-Lobenhoffer J; Hammwöhner M; Röhl FW; Bukowska A; Ghanem A; Klein HU; Bode-Böger SM
    Europace; 2011 Oct; 13(10):1428-35. PubMed ID: 21752828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
    Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
    Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children.
    Takaya J; Tanabe Y; Kuroyanagi Y; Kaneko K
    Endocr J; 2015; 62(6):551-6. PubMed ID: 25903645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes.
    Onat A; Köroğlu B; Can G; Karagöz A; Yüksel M; Aydın M
    Anadolu Kardiyol Derg; 2014 Feb; 14(1):26-33. PubMed ID: 24342929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
    Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
    Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
    Hsu CP; Hsu PF; Chung MY; Lin SJ; Lu TM
    Cardiovasc Diabetol; 2014 Dec; 13():156. PubMed ID: 25467091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
    Sibal L; Agarwal SC; Schwedhelm E; Lüneburg N; Böger RH; Home PD
    Cardiovasc Diabetol; 2009 Jun; 8():27. PubMed ID: 19486510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
    Böger RH; Sullivan LM; Schwedhelm E; Wang TJ; Maas R; Benjamin EJ; Schulze F; Xanthakis V; Benndorf RA; Vasan RS
    Circulation; 2009 Mar; 119(12):1592-600. PubMed ID: 19289633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum apelin and ADMA levels in type 2 diabetics with and without vascular complications.
    Karakoç A; Sahin A; Polat ES; Aliyev E; Yildirim A; Bakan N; Dokumacioglu E
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S106-9. PubMed ID: 27083312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of asymmetrical dimethylarginine levels with renal outcomes in hypertensive patients with and without type 2 diabetes mellitus.
    Triches CB; Quinto M; Mayer S; Batista M; Zanella MT
    J Diabetes Complications; 2018 Mar; 32(3):316-320. PubMed ID: 29398328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Hanai K; Babazono T; Nyumura I; Toya K; Tanaka N; Tanaka M; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2009 Jun; 24(6):1884-8. PubMed ID: 19131352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.